Abstract
This chapter examines some inter-operative aspects of thyroid physiology and adipose tissue. There are also observational reports confirming (or not) the link between autoimmune thyroid disease, thyroid cancer, thyroid physiopathology, and obesity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
https://www.oecd.org/els/health-systems/Obesity-Update-2017.pdf
https://www.epicentro.iss.it/okkioallasalute/indagine-2019-dati
Peter L, et al. Thyroid function and obesity. Eur Thyroid J. 2012;1:159–67. https://doi.org/10.1159/000342994.
Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid. 2013;23(6):646–53.
Amouzegar A, et al. Abdominal obesity phenotypes and incidence of thyroid autoimmunity: a 9-year follow-up. Endocr Res. 2020;45(3):202–9. https://doi.org/10.1080/07435800.2020.1749847.
Rotondi M, et al. Raised serum TSH levels in patients with soft obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol. 2009;160:403–8. https://doi.org/10.1530/EJE-08-0734.
Stichel H, et al. Thyroid function and obesity in children and adolescents. Horm Res. 2000;54:14–9. https://doi.org/10.1159/000063431.
Song R-H, et al. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front Immunol. 2019;10:2349.
Fierabracci P, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21:2154–60. https://doi.org/10.1007/s11695-010-0297-6.
Marzullo P, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab. 2010;95:3965–72. https://doi.org/10.1210/jc.2009-2798.
Wu Y, et al. The correlation between metabolic disorders and tpoab/tgab: a cross-sectional population-based study. Endocr Pract. 2020;26(8):869–82.
Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, Puckett M, Richardson LC. Vital signs: trends in incidence of cancers associated with overweight and obesity—United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2017;66(39):1052–8. https://doi.org/10.15585/mmwr.mm6639e1.
Kitahara CM, Pfeiffer RM, Sosa JA, Shiels MS. Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995–2015). J Natl Cancer Inst. 2020;112(8):djz202. https://doi.org/10.1093/jnci/djz202.
Fussey JM, Beaumont RN, Wood AR, et al. Does obesity cause thyroid cancer? a mendelian randomization study. J Clin Endocrinol Metab. 2020;105:e2398–407.
Han JM, et al. Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol. 2013;168:879–86. https://doi.org/10.1530/EJE-13-0065.
Kim HJ, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf). 2013;78(1):134–40. https://doi.org/10.1111/j.1365-2265.2012.04506.x.
Chen J, Cao H, Lian M, Fang J. Five genes influenced by obesity may contribute to the development of thyroid cancer through the regulation of insulin levels. Peer J. 2020;8:e9302. https://doi.org/10.7717/peerj.9302.
Rahman ST, Pandeya N, Neale RE, Mcleod DSA, Bain CJ, Baade PD, et al. Obesity is associated with BRAFV600E-mutated thyroid cancer. Thyroid. 2020;30(10):1518–27. https://doi.org/10.1089/thy.2019.0654.
Choi JS, et al. The influence of body mass index on the diagnostic performance of pre-operative staging ultrasound in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2015;83(4):550–5. https://doi.org/10.1111/cen.12638.
de Siqueira RA, et al. Thyroid nodules in severely obese patients: frequency and risk of malignancy on ultrasonography. Endocr Res. 2019;1:1–8. https://doi.org/10.1080/07435800.2019.1625056.
Mario R, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol. 2009;160:403–8. https://doi.org/10.1530/EJE-08-0734.
Reinehr T, et al. Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002;87:320–3. https://doi.org/10.1136/adc.87.4.320.
Ehrenkranz J, et al. Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid. 2015;25(8):954–61. https://doi.org/10.1089/thy.2014.0589.
Yoshihara A, et al. Seasonal changes in serum thyrotropin concentrations observed from big data obtained during six consecutive years from 2010 to 2015 at a single Hospital in Japan. Thyroid. 2018;28(4):429–36. https://doi.org/10.1089/thy.2017.0600.
Peter L, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006;155:219–28. https://doi.org/10.1530/eje.1.02210.
Nyrnes A, et al. Serum TSH is positively associated with BMI. Int J Obes (Lond). 2006;30:100–5. https://doi.org/10.1038/sj.ijo.0803112.
Kitahara CM, et al. Body fatness and markers of thyroid function among U.S. men and women. PLoS One. 2012;7(4):e34979. https://doi.org/10.1371/journal.pone.0034979.
Lu S, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis. 2012;11:17. https://doi.org/10.1186/1476-511X-11-17.
Draman MS, et al. The role of thyrotropin receptor activation in adipogenesis and modulation of fat phenotype. Front Endocrinol. 2017;8:83. https://doi.org/10.3389/fendo.2017.00083.
Juiz-Valiña P, et al. Effect of weight loss after bariatric surgery on thyroid-stimulating hormone levels in euthyroid patients with morbid obesity. Nutrients. 2019;11:1121. https://doi.org/10.3390/nu11051121.
Guan B, et al. Effect of bariatric surgery on thyroid function in obese patients: a systematic review and meta-analysis. Obes Surg. 2017;27:3292–305. https://doi.org/10.1007/s11695-017-2965-2.
Zhang H, et al. Effect of laparoscopic roux-en-Y gastric bypass surgery on thyroid hormone levels in Chinese patients, could it be a risk for thyroid nodules? Obes Surg. 2017;27:2619–27. https://doi.org/10.1007/s11695-017-2684-8.
Gianluca I, et al. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005;62(4):487–91. https://doi.org/10.1111/j.1365-2265.2005.02247.x.
Carlo C, et al. Morbid obesity in women is associated to a lower prevalence of thyroid nodules. Obes Surg. 2012;22:460–4. https://doi.org/10.1007/s11695-011-0410-5.
Spadafranca A, et al. Relationship between thyroid hormones, resting energy expenditure and cardiometabolic risk factors in euthyroid subjects. Clin Nutr. 2015;34(4):674–8. https://doi.org/10.1016/j.clnu.2014.07.014.
Kim JM, et al. The relationship between thyroid function and different obesity phenotypes in Korean euthyroid adults. Diabetes Metab J. 2019;43(6):867–78. https://doi.org/10.4093/dmj.2018.0130.
Kim MT, et al. Changes in body compositions and basal metabolic rates during treatment of Graves’ disease. Int J Endocrinol. 2018;2018:9863050. https://doi.org/10.1155/2018/9863050.
de la Rosa RE, et al. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis. Thyroid. 1997;7(3):401–5. https://doi.org/10.1089/thy.1997.7.401.
Lönn L, et al. Body weight and body composition changes after treatment of hyperthyroidism. J Clin Endocrinol Metab. 1998;83:4269–73. https://doi.org/10.1210/jcem.83.12.5338.
Mariantonella T, et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res. 2001;9(3):197–201.
Marzullo P, et al. The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity. PLoS One. 2018;13:e0205293. https://doi.org/10.1371/journal.pone.0205293.
Samuels MH, et al. Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition. Thyroid. 2016;26:347–55. https://doi.org/10.1089/thy.2015.0345.
Josh W, et al. Do patients gain weight after thyroidectomy for thyroid cancer? Thyroid. 2011;21(12):1339–42. https://doi.org/10.1089/thy.2010.0393.
Karmisholt J, et al. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J Clin Endocrinol Metab. 2011;96(1):E99–E103. https://doi.org/10.1210/jc.2010-1521.
Gabrilove JL, et al. The histogenesis of myxedema. J Clin Endocrinol Metab. 1957;17:925–32. https://doi.org/10.1210/jcem-17-8-925.
Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab. 2011;96(11):3466–74. https://doi.org/10.1210/jc.2011-1329.
Jonklaas J, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24:1670–751. https://doi.org/10.1089/thy.2014.0028.
Pearce SHS, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28. https://doi.org/10.1159/000356507.
Cannon B, et al. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.
de Jesus LA, et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest. 2001;108(9):1379–85. https://doi.org/10.1172/JCI200113803.
Lindsey RC, et al. Thyroid hormone acting via TRβ induces expression of browning genes in mouse bone marrow adipose tissue. Endocrine. 2017;56:109–20. https://doi.org/10.1007/s12020-017-1265-x.
Yau WW, et al. Thyroid hormone (T3) stimulates brown adipose tissue activation via mitochondrial biogenesis and MTOR-mediated mitophagy. Autophagy. 2019;15:131–50. https://doi.org/10.1080/15548627.2018.1511263.
Lee J-Y, Takahashi N, Yasubuchi M, Kim Y-I, Hashizaki H, Kim M-J, et al. Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes. Am J Physiol Cell Physiol. 2012;302:C463–72. https://doi.org/10.1152/ajpcell.00010.2011.
Silva JE, et al. Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature. 1983;305:712–3.
Rehnmark S, et al. Brown adipocytes differentiated in vitro can express the gene for the uncoupling protein thermogenin: effects of hypothyroidism and norepinephrine. Exp Cell Res. 1989;182(1):75–83. https://doi.org/10.1016/0014-4827(89)90280-2.
Lin JZ, et al. Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to Brown fat. Cell Rep. 2015;13:1528–37. https://doi.org/10.1016/j.celrep.2015.10.022.
Gong D-W, et al. Uncoupling Protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β3-adrenergic agonists, and leptin. J Biol Chem. 1997;272:24129–32. https://doi.org/10.1074/jbc.272.39.24129.
Pohl EE, et al. Important trends in UCP3 investigation. Front Physiol. 2019;10:470. https://doi.org/10.3389/fphys.2019.00470.
Pierre B, et al. Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes. FASEB J. 2001;15(1):13–5. https://doi.org/10.1096/fj.00-0502fje.
Flandin P, et al. Uncoupling protein-3 as a molecular determinant of the action of 3,5,3′-triiodothyronine on energy metabolism. Endocrine. 2009;36:246–54. https://doi.org/10.1007/s12020-009-9217-8.
Phillips KJ. Beige fat, adaptive thermogenesis, and its regulation by exercise and thyroid hormone. Biology. 2019;8:57. https://doi.org/10.3390/biology8030057.
Dittner C, et al. At thermoneutrality, acute thyroxine-induced thermogenesis and pyrexia are independent of UCP1. Mol Metab. 2019;25:20–34.
Johann K, et al. Thyroid-hormone-induced browning of white adipose tissue does not contribute to thermogenesis and glucose consumption. Cell Rep. 2019;27:3385–3400.e3.
Zhang Q, et al. The effects of thyroid hormones on brown adipose tissue in humans: a PET-CT study. Diabetes Metab Res Rev. 2014;30(6):513–20. https://doi.org/10.1002/dmrr.2556.
Haber RS, et al. Stimulation of potassium efflux in rat liver by a low dose of thyroid hormone: evidence for enhanced cation permeability in the absence of Na,K-ATPase induction. Endocrinology. 1986;118(1):207–11.
Haber RS, et al. Time course of Na,K transport and other metabolic responses to thyroid hormone in clone 9 cells. Endocrinology. 1988;123(1):238–47.
Freake HC, et al. The regulation of lipogenesis by thyroid hormone and its contribution to thermogenesis. Endocrinology. 1989;125(6):2868–74.
Everts ME, et al. Na(+)-K+ pump in rat muscle: effects of hypophysectomy, growth hormone, and thyroid hormone. Am J Physiol. 1990;259:E278–83. https://doi.org/10.1152/ajpendo.1990.259.2.E278.
Phakdeekitcharoen B, et al. Thyroid hormone increases mRNA and protein expression of Na(+)-K(+)-ATPase α2 and β1 subunits in human skeletal muscles. J Clin Endocrinol Metab. 2007;92(1):353–8. https://doi.org/10.1210/jc.2006-0552.
Marie V, et al. Calcium pool size modulates the sensitivity of the ryanodine receptor channel and calcium-dependent ATPase of heavy sarcoplasmic reticulum to extravesicular free calcium concentration. J Cell Physiol. 1998;175:283–94. https://doi.org/10.1002/(SICI)1097-4652(199806)175:3<283::AID-JCP6>3.0.CO;2-K.
Simonides WS, et al. Characterization of the promoter of the rat sarcoplasmic endoplasmic reticulum Ca2+-ATPase 1 gene and Analysis of thyroid hormone responsiveness. J Biol Chem. 1996;271:32048–56.
Watanabe M, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484–9. https://doi.org/10.1038/nature04330.
Johansson C, et al. Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-β or both α1 and β. Am J Physiol. 1999;276(6):H2006–12. https://doi.org/10.1152/ajpheart.1999.276.6.H2006.
Ribeiro MO, et al. Thyroid hormone–sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform–specific. J Clin Invest. 2001;108:97–105. https://doi.org/10.1172/JCI200112584.
Miguel L, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16(9):1001–8. https://doi.org/10.1038/nm.2207.
Boelen A, et al. Fasting-induced changes in the hypothalamus–pituitary–thyroid axis. Thyroid. 2008;18:123–9. https://doi.org/10.1089/thy.2007.0253.
Date Y, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.
Kanamoto N, et al. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab. 2001;6:4984–90. https://doi.org/10.1210/jcem.86.10.7891.
Ahangarpour A, et al. Regulatory effects of paraventricular nucleus injections of ghrelin on the hypothalamus-pituitary-thyroid axis via CB1 receptors in male rats. Neurochem J. 2016;10:205–10.
Barington M, et al. Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivo. PLoS One. 2017;12:e0184992. https://doi.org/10.1371/journal.pone.0184992.
Morillo-Bernal J, et al. Ghrelin potentiates TSH-induced expression of the thyroid tissue-specific genes thyroglobulin, thyroperoxidase and sodium-iodine symporter, in rat PC-Cl3 cells. Peptides. 2011;32:2333–9. https://doi.org/10.1016/j.peptides.2011.09.013.
Röjdmark S, et al. Hunger-satiety signals in patients with Graves’ thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine. 2005;27:55–61.
Ruchala M, et al. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state. Peptides. 2014;51:31–4. https://doi.org/10.1016/j.peptides.2013.10.018.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
De Geronimo, V. (2021). Thyroid and Obesity. In: Luzi, L. (eds) Thyroid, Obesity and Metabolism. Springer, Cham. https://doi.org/10.1007/978-3-030-80267-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-80267-7_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80266-0
Online ISBN: 978-3-030-80267-7
eBook Packages: MedicineMedicine (R0)